Clinical Evaluation of the Anti-Wrinkle Efficacy of Two Cosmetic Products (Test Product vs. Control Product)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011965

Enrollment

Registered

2026-05-12

Start date

2023-02-08

Completion date

Unknown

Last updated

2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cosmetics) : The test product was a white ampoule containing 0.5% hydrolyzed fish skin extract, while the control product was a placebo formulation that did not contain the active ingredient. T

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Male and female subjects aged 30 to 65 years who, in the opinion of the principal investigator, had skin wrinkles of grade 3 or higher on the test area according to the standard photographic scale. ? Healthy subjects without acute or chronic physical diseases, including skin disorders. ? Volunteers who were fully informed about the purpose and procedures of the study and voluntarily signed the informed consent form. ? Volunteers who were available for follow-up evaluations throughout the study period.

Exclusion criteria

Exclusion criteria: ? Pregnant or breastfeeding women, or women who were planning to become pregnant during the study period. ? Subjects who had used topical formulations containing steroids for more than one month for the treatment of skin diseases. ? Subjects who had participated in the same or a similar clinical study within the previous 6 months. ? Subjects with sensitive or hypersensitive skin. ? Subjects showing abnormal skin conditions on the test area, such as moles, acne, erythema, or telangiectasia. ? Subjects who had used the same or similar cosmetic products or medications on the test area within 3 months prior to the start of the study. ? Subjects who had undergone skin procedures on the test area (such as skin peeling, botulinum toxin injection, wrinkle treatment procedures, or other skin care procedures), or who planned to undergo such procedures within 6 months. ? Subjects with chronic wasting diseases (e.g., asthma, diabetes mellitus, hypertension, etc.). ? Subjects deemed unsuitable for participation in the study at the discretion of the principal investigator.

Design outcomes

Primary

Measure	Time frame
Wrinkle Parameter Analysis Using 3D Image Analysis	—

Secondary

Measure	Time frame
Visual Evaluation of Skin Wrinkles ;Subject Questionnaire Assessment	—

Countries

Korea, Republic of

Contacts

Public ContactJae Sook Koh

DERMAPRO

dermapro@dermapro.co.kr+82-2-597-5434

Outcome results